This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
OPKO Health (OPK) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
OPKO Health (OPK) delivered earnings and revenue surprises of -58.33% and -5.09%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Sensus Healthcare, Inc. (SRTS) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
In the most recent trading session, Sensus Healthcare, Inc. (SRTS) closed at $5.51, indicating a -2.48% shift from the previous trading day.
Why Sensus Healthcare, Inc. (SRTS) Outpaced the Stock Market Today
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) reached $4.44 at the closing of the latest trading day, reflecting a +2.54% change compared to its last close.
Sensus Healthcare, Inc. (SRTS) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) closed at $4.16 in the latest trading session, marking a -9.17% move from the prior day.
Sensus Healthcare, Inc. (SRTS) Declines More Than Market: Some Information for Investors
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) closed at $4.64 in the latest trading session, marking a -2.11% move from the prior day.
Sensus Healthcare, Inc. (SRTS) Stock Moves 1.91%: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Sensus Healthcare, Inc. (SRTS) stood at $4.80, denoting a +1.91% move from the preceding trading day.
Is It Worth Investing in Sensus Healthcare (SRTS) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Sensus Healthcare (SRTS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sensus Healthcare (SRTS) delivered earnings and revenue surprises of -500% and 14.77%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
DarioHealth (DRIO) delivered earnings and revenue surprises of 14.29% and 10.21%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
NeuroPace (NPCE) delivered earnings and revenue surprises of 19.23% and 2.87%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Sensus Healthcare, Inc. (SRTS) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $4.22, marking a -0.47% move from the previous day.
Sensus Healthcare, Inc. (SRTS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) closed at $4.33 in the latest trading session, marking a +0.7% move from the prior day.
Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q1 Earnings Expected to Decline
by Zacks Equity Research
Sensus Healthcare (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Sensus Healthcare (SRTS) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Sensus Healthcare (SRTS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Sensus Healthcare, Inc. (SRTS) Rises Yet Lags Behind Market: Some Facts Worth Knowing
by Zacks Equity Research
In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $4.69, marking a +1.3% move from the previous day.
Sensus Healthcare, Inc. (SRTS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) reachead $4.72 at the closing of the latest trading day, reflecting a +1.51% change compared to its last close.
Sensus Healthcare, Inc. (SRTS) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) reachead $4.48 at the closing of the latest trading day, reflecting a +0.45% change compared to its last close.
Sensus Healthcare, Inc. (SRTS) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) closed the most recent trading day at $4.69, moving +1.08% from the previous trading session.
Here's Why Sensus Healthcare, Inc. (SRTS) Gained But Lagged the Market Today
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) closed the most recent trading day at $4.78, moving +0.84% from the previous trading session.
Brokers Suggest Investing in Sensus Healthcare (SRTS): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Sensus Healthcare (SRTS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Implied Volatility Surging for Sensus Healthcare (SRTS) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Sensus Healthcare (SRTS) stock based on the movements in the options market lately.
Sensus Healthcare, Inc. (SRTS) Lags Q4 Earnings Estimates
by Zacks Equity Research
Sensus Healthcare (SRTS) delivered earnings and revenue surprises of -10% and 32.59%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Sensus Healthcare (SRTS) Moves 19.9% Higher: Will This Strength Last?
by Zacks Equity Research
Sensus Healthcare (SRTS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Sensus Healthcare, Inc. (SRTS) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) closed at $6.92 in the latest trading session, marking a +1.91% move from the prior day.
Sensus Healthcare, Inc. (SRTS) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
Sensus Healthcare, Inc. (SRTS) reachead $6.77 at the closing of the latest trading day, reflecting a +1.96% change compared to its last close.